- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02009228
Single-port LC Might be Preferable for Managing Ovarian Dermoid Cyst.
December 8, 2013 updated by: vghtpe user, Taipei Veterans General Hospital, Taiwan
Single-Port Compared With Conventional Laparoscopic Cystectomy for Ovarian Dermoid Cysts
Minimally invasive surgery has become the standard treatment for many gynecologic disease processes.
In the last decade, numerous studies have demonstrated that laparoscopic approaches to various gynecologic oncology conditions-particularly for early-stage endometrial and cervical cancers as well as select pelvic masses-is feasible and results in shorter hospital stays, improved quality of life and comparable surgical and oncologic outcomes to abdominal staging.For instance, the typical gynecologic robotic surgical procedure will require Two to three 5-mm ports and one 12-mm laparoscopic ports.
Recently, an even less invasive alternative to conventional laparoscopy surgery has been developed: laparoendoscopic single-site surgery (LESS), also known as single-port surgery.
Single port laparoscopy is an attempt to further enhance the cosmetic benefits of minimally invasive surgery while minimizing the potential morbidity associated with multiple incisions.
Preliminary advances in LESS as applied to urologic and gastrointestinal surgery demonstrate that the techniques are feasible provided that both optimal surgical technical expertise with advanced skills and optimal instrumentation are available.
Recently, several publication showed the single port laparoscopic surgery is feasibility in gynecologic surgery including oophorectomy, cystecomty, and myomecomty.
To our knowledge, the sample size of recent publication about single port surgery including cystectomy and myomecomty is small.
Furthermore, these studies lack the comparison of single port and convectional laparoscopic surgery.
Base on our recent study demonstrated that either the single-port or the conventional approach can be used for LAVH, but the single-port LAVH technique yielded less postoperative pain (Chen et al., Obestet Gynecol, 2011).
The purpose of this study was to assess the feasibility of single port laparoscopic surgery in the treatment of benign gynecologic disease.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This study was designed as a retrospective case-control study, and port placement was one of the differences in operative procedures between the two groups.
Patients with ovarian dermoid cysts were evaluated at Taipei Veterans General Hospital from June 13, 2011 through June 12, 2013.
Approval for the study was obtained from the hospital's ethics committee, and informed consent was obtained from all patients (VGHIRB 2011-06-004IA).
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 11217
- Taipei Veteran General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- the patient received cystectomy for ovarian dermoid cysts (even while pregnant), the cyst received an American Society of Anesthesiologists physical status classification of I or II, and the patient provided signed informed consent.
Exclusion Criteria:
- patients who received an oophorectomy for dermoid cyst or had a dermoid ovarian cyst with malignant potential and concomitant surgeries for uterine lesion, pelvic organ prolapse or urodynamic urinary incontinence were excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Single-port laparoscopy
The three-channel single-port: a 1.5-cm horizontal intraumbilical skin incision, a 1.5-cm to 2-cm rectus fasciotomy to open the peritoneal cavity, and the insertion of an Alexis small wound retractor (Applied Medical, Rancho Santa Margarita, CA).
The wrist portion of a size 6.5 surgical glove was fixed to the outer ring of the wound retractor.
A 12-mm trocar was inserted through a small hole made in one of the fingertips of the glove and advanced into the abdominal cavity.
Two additional holes for the accessory channels were made in another fingertip of the glove, and two conventional 5-mm trocars were inserted through the holes.
|
Other Names:
|
|
Active Comparator: Conventional laparoscopy
The 12-mm main troca was inserted via subumbilical incision after fully insufflation by verness needle and other 3 working 5-mm trocas were inserted under vision at right middle abdominal, left middle abdominal and suprapubic incisions.
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The outcome measures and ovarian reserve between single-port and conventional laparoscopic cystectomy in managing ovarian dermoid cysts.
Time Frame: The first 48 hours and 4 weeks after the surgery
|
The outcome measures included operative time, blood loss, postoperative pain, and analgesic use in the first 48 hours after surgery.
|
The first 48 hours and 4 weeks after the surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ovarian reserve were compared with single-port and conventional laparoscopic cystectomy in managing ovarian dermoid cysts.
Time Frame: Before and 4 weeks after surgery.
|
Ovarian reserve markers include serum estrogen (E2), follicle-stimulating hormone (FSH), luteinizing hormone (LH), and anti-Mullerian hormone (AMH) before and 4 weeks after surgery.
|
Before and 4 weeks after surgery.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ovarian spillage and endobag rupture rates were compared between single-port and conventional laparoscopic cystectomy in managing ovarian dermoid cysts.
Time Frame: During operation.
|
The ovarian spillage and endobag rupture rates were compared between single-port and conventional laparoscopic cystectomy in managing ovarian dermoid cysts during operation.
|
During operation.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Ben-Shian Huang, M.D., Taipei Veterans General Hospital, National Yang Ming University Hosiptal, Ilan, Taiwan
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2011
Primary Completion (Actual)
June 1, 2013
Study Completion (Actual)
June 1, 2013
Study Registration Dates
First Submitted
December 8, 2013
First Submitted That Met QC Criteria
December 8, 2013
First Posted (Estimate)
December 11, 2013
Study Record Updates
Last Update Posted (Estimate)
December 11, 2013
Last Update Submitted That Met QC Criteria
December 8, 2013
Last Verified
December 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011-06-004IA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Pain
-
Yaqi Shen,MD,PhDUnited Imaging HealthcareActive, not recruiting
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaCompletedFunctional Gastrointestinal Disorders | Functional Abdominal Pain Syndrome | Abdominal Pain (AP)
-
University of WashingtonUniversity of North Carolina; MultiCare Mary Bridge Children's Hospital & Health...Completed
-
University of MichiganTerminatedFunctional Abdominal PainUnited States
-
University of BariClinica PEdiatrica Ospedale San Paolo Bari ItalyCompletedFunctional Abdominal PainItaly
-
National Center for Complementary and Integrative...CompletedRecurrent Abdominal PainUnited States
-
Duke UniversityCompletedFunctional Abdominal PainUnited States
-
Children's Mercy Hospital Kansas CityUniversity of ArizonaCompletedFunctional Abdominal Pain
-
The Third Xiangya Hospital of Central South UniversityRecruiting
-
Anna DubergÖrebro University, Sweden; Region VästmanlandCompletedFunctional Abdominal Pain | IBSSweden
Clinical Trials on Ovarian cystectomy
-
Shandong Provincial HospitalShandong UniversityCompleted
-
Shandong Provincial HospitalShandong UniversityCompleted
-
Imperial College LondonUniversity College London HospitalsRecruitingBenign Ovarian CystUnited Kingdom
-
Shaimaa Mostafa Mohammed Refaay El shemyCompletedOvarian EndometriomaEgypt
-
Saad AmerUniversity Hospitals of Derby and Burton NHS Foundation TrustUnknown
-
Kafrelsheikh UniversityRecruiting
-
University Hospital, Clermont-FerrandCentre Imagerie Cellulaire Santé, Faculté Médecine et Pharmacie, CLERMONT...CompletedOvarian Cysts | Endometriosis | FertilityFrance
-
Seoul National University HospitalRecruitingBenign Ovarian CystKorea, Republic of
-
Al-Azhar UniversityCompletedComplex Ovarian CystEgypt
-
Seoul National University HospitalCompletedOvarian Cyst BenignKorea, Republic of